This Startup Wants to Put Its Brain-Computer Interface in the Apple Vision Pro

Cognixion, a California-based startup, is launching a clinical trial to enable paralyzed patients with speech disorders to communicate without invasive brain implants. The company's brain-computer interface (BCI) technology aims to be integrated into the upcoming Apple Vision Pro mixed reality headset. The trial will assess the safety and efficacy of Cognixion's non-invasive BCI, which uses electroencephalography (EEG) to detect brain signals and translate them into digital commands. This technology could provide a new communication method for individuals with conditions like amyotrophic lateral sclerosis (ALS) or locked-in syndrome. If successful, the integration of Cognixion's BCI into the Apple Vision Pro could significantly improve accessibility and assistive capabilities for users with disabilities. The partnership with a major technology company like Apple also highlights the growing interest and potential of BCI technologies in the consumer and healthcare domains. The clinical trial represents an important step in advancing non-invasive BCI solutions and their potential to enhance the quality of life for individuals with speech and mobility impairments.